Atherosclerosis in the Apolipoprotein E–Deficient Mouse
Top Cited Papers
- 1 June 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (6) , 1006-1014
- https://doi.org/10.1161/01.atv.0000128849.12617.f4
Abstract
Arguably the most critical advancement in the elucidation of factors affecting atherogenesis has been the development of mouse models of atherosclerosis. Among available models, the apolipoprotein E–deficient (apoE−/−) mouse is particularly popular because of its propensity to spontaneously develop atherosclerotic lesions on a standard chow diet. A Medline search reveals over 645 articles dedicated to studies using this reliable and convenient “super” animal model since its inception (Piedrahita JA et al, Proc Natl Acad Sci U S A 1992;89:4471–4475; Plump AS et al, Cell 1992;71:343–353) with a more or less steady increase from year to year. This review will examine our present understanding of the pathology and progression of plaques in this animal and highlight some of the nutritional, pharmacological, and genetic studies that have enhanced this understanding.Keywords
This publication has 72 references indexed in Scilit:
- Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 DiabetesCirculation, 2003
- Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor γ and hepatocyte nuclear factor 4αBiochemical and Biophysical Research Communications, 2003
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003
- Characterization of aortic root atherosclerosis in ApoE knockout mice: High‐resolution in vivo and ex vivo MRM with histological correlationMagnetic Resonance in Medicine, 2003
- Increased ABCA1 activity protects against atherosclerosisJournal of Clinical Investigation, 2002
- Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.Journal of Clinical Investigation, 1998
- The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient MiceBiochemical and Biophysical Research Communications, 1997
- Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory propertiesAtherosclerosis, 1994
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992